Here’s what you need to know:
1. Current investors New Enterprise Associates, Life Sciences Partners and Pappas Ventures all participated in the funding, which is fundable in two phases: $8 million upfront and $4 million in 2017.
2. The company will use the funding to continue United States-based marketing of the Rotation Medical rotator cuff system, which is a proprietary bioinductive implant and disposable instruments.
3. Traditional rotator cuff surgeries do not address the poor quality of underlying tendon tissue, and a significant number of these tendons either degenerate or re-tear after treatment. The Rotation Medical implant is designed to address this limitation.
More news related to medical devices:
1. Spinal Elements’ interspinous process device receives FDA clearance: 5 observations
2. Ronda Stryker sells 12k company shares with value of $1.38M — 5 key points
3. Children’s Mercy leverages 3D printing to enhance orthopedics surgeries: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
